Sky Blue 11 Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Sky Blue 11.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Semiconductor	14.6%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Balk 1798 Group Limited (HKG:1010) Soars 29% But It's A Story Of Risk Vs Reward

Mar 14

It's Down 26% But Balk 1798 Group Limited (HKG:1010) Could Be Riskier Than It Looks

Jan 23

Not Many Are Piling Into Balk 1798 Group Limited (HKG:1010) Stock Yet As It Plummets 26%

Jan 22

If You Had Bought PacRay International Holdings' (HKG:1010) Shares Three Years Ago You Would Be Down 34%

Jan 13

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Sky Blue 11 no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

SEHK:1010 - Estimaciones futuras de los analistas y datos financieros pasados (HKD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2023	114	-46	N/A	N/A	N/A
9/30/2023	177	-17	N/A	N/A	N/A
6/30/2023	239	12	21	21	N/A
3/31/2023	210	5	20	20	N/A
12/31/2022	181	-2	20	20	N/A
9/30/2022	138	-30	-56	-55	N/A
6/30/2022	95	-57	-132	-130	N/A
3/31/2022	100	-55	-133	-131	N/A
12/31/2021	106	-53	-134	-132	N/A
9/30/2021	109	-34	-59	-57	N/A
6/30/2021	112	-15	17	17	N/A
3/31/2021	102	-10	20	20	N/A
12/31/2020	93	-5	23	23	N/A
9/30/2020	91	-10	19	17	N/A
6/30/2020	89	-14	14	11	N/A
3/31/2020	82	-17	3	2	N/A
12/31/2019	74	-21	-9	-8	N/A
9/30/2019	60	-32	-20	-18	N/A
6/30/2019	45	-43	-31	-29	N/A
3/31/2019	53	-42	-33	-30	N/A
12/31/2018	61	-40	-35	-32	N/A
9/30/2018	61	-24	-42	-38	N/A
6/30/2018	61	-7	-49	-44	N/A
3/31/2018	49	-5	-34	-31	N/A
12/31/2017	37	-3	-19	-19	N/A
9/30/2017	29	0	N/A	-8	N/A
6/30/2017	21	3	N/A	3	N/A
3/31/2017	19	-1	N/A	-3	N/A
12/31/2016	17	-5	N/A	-9	N/A
9/30/2016	16	-14	N/A	-9	N/A
6/30/2016	14	-23	N/A	-9	N/A
3/31/2016	14	-24	N/A	-12	N/A
12/31/2015	14	-25	N/A	-14	N/A
9/30/2015	14	-22	N/A	-13	N/A
6/30/2015	14	-19	N/A	-12	N/A
3/31/2015	14	-1	N/A	-9	N/A
12/31/2014	14	17	N/A	-6	N/A
9/30/2014	13	20	N/A	-8	N/A
6/30/2014	13	23	N/A	-9	N/A
3/31/2014	13	34	N/A	-10	N/A
12/31/2013	12	46	N/A	-10	N/A
9/30/2013	11	49	N/A	-10	N/A
6/30/2013	10	51	N/A	-10	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de 1010 es superior a la tasa de ahorro (2%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de 1010 crezcan más rápidamente que el mercado Hong Kong

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de 1010 crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de 1010 crezcan más rápidamente que el mercado de Hong Kong.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de 1010 crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de 1010 se prevé que sea elevada dentro de 3 años.

Sky Blue 11 Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

PacRay International Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2021

PacRay International Holdings Limited Provides Earnings Guidance for the Year Ended December 31, 2020

Recent updates

New major risk - Negative shareholders equity

Full year 2023 earnings released: HK$0.13 loss per share (vs HK$0.006 loss in FY 2022)

Now 22% overvalued

Balk 1798 Group Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Balk 1798 Group Limited (HKG:1010) Soars 29% But It's A Story Of Risk Vs Reward

Now 22% overvalued

Now 44% overvalued

It's Down 26% But Balk 1798 Group Limited (HKG:1010) Could Be Riskier Than It Looks

Not Many Are Piling Into Balk 1798 Group Limited (HKG:1010) Stock Yet As It Plummets 26%

New minor risk - Shareholder dilution

New minor risk - Market cap size

Investor sentiment deteriorates as stock falls 39%

Does Balk 1798 Group (HKG:1010) Have A Healthy Balance Sheet?

New minor risk - Share price stability

Investor sentiment improves as stock rises 31%

First half 2023 earnings released: HK$0.002 loss per share (vs HK$0.042 loss in 1H 2022)

Balk 1798 Group Limited to Report First Half, 2023 Results on Aug 30, 2023

Shareholders Should Be Pleased With Balk 1798 Group Limited's (HKG:1010) Price

Balk 1798 Group Limited, Annual General Meeting, Jun 06, 2023

High number of new and inexperienced directors

Balk 1798 Group (HKG:1010) Takes On Some Risk With Its Use Of Debt

High number of new and inexperienced directors

First half 2022 earnings released: HK$0.042 loss per share (vs HK$0.029 loss in 1H 2021)

PacRay International Holdings Limited Announces Executive Changes

First half 2022 earnings released: HK$0.042 loss per share (vs HK$0.029 loss in 1H 2021)

PacRay International Holdings Limited to Report First Half, 2022 Results on Aug 30, 2022

PacRay International Holdings Limited, Annual General Meeting, Jun 06, 2022

High number of new and inexperienced directors

Full year 2021 earnings released: HK$0.14 loss per share (vs HK$0.016 loss in FY 2020)

PacRay International Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2021

PacRay International Holdings Limited Appoints Wang Yi as the Executive Director, with Effect from March 8, 2022

PacRay International Holdings Limited Announces Resignation of Duan Hongtao as Executive Director and Chairman of the Board

Non-Executive Director & Company Secretary Danqing Zhou has left the company

Executive Director Yinsheng Xu has left the company

First half 2021 earnings released: HK$0.029 loss per share (vs HK$0.004 loss in 1H 2020)

Executive Director Lin Yang has left the company

Executive Director has left the company

Independent Non-Executive Director has left the company

Executive Director has left the company

Full year 2020 earnings released: HK$0.016 loss per share (vs HK$0.063 loss in FY 2019)

PacRay International Holdings Limited Provides Earnings Guidance for the Year Ended December 31, 2020

PacRay International Holdings Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

New 90-day high: HK$1.96

Zhongying Int’l Holding Group Limited completed the acquisition of 45.1% stake in PacRay International Holdings Limited (SEHK:1010) from Vision2000 Venture Ltd. and other shareholders for approximately HKD 230 million.

If You Had Bought PacRay International Holdings' (HKG:1010) Shares Three Years Ago You Would Be Down 34%

Zhongying Int’l Holding Group Limited made an offer to acquire 56.34% stake in PacRay International Holdings Limited (SEHK:1010) from Vision2000 Venture Ltd. and other shareholders for approximately HKD 280 million.

New 90-day high: HK$0.90

New 90-day low: HK$0.70

First half earnings released

PacRay International Holdings Limited (SEHK:1010) completed the acquisition of 20.2% stake in Meridian Aviation Holdings Limited from Duan Hong Tao and Wang Yi.

First half earnings released

Pacray International Holdings Limited Announces Resignation of Xu Beinan as Chief Executive Officer

PacRay International Holdings Limited to Report First Half, 2020 Results on Aug 28, 2020

New 90-day high - HK$1.79

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento